IL249705A0 - חיסונים נגד נגיף השפעת ושימושים בהם - Google Patents

חיסונים נגד נגיף השפעת ושימושים בהם

Info

Publication number
IL249705A0
IL249705A0 IL249705A IL24970516A IL249705A0 IL 249705 A0 IL249705 A0 IL 249705A0 IL 249705 A IL249705 A IL 249705A IL 24970516 A IL24970516 A IL 24970516A IL 249705 A0 IL249705 A0 IL 249705A0
Authority
IL
Israel
Prior art keywords
influenza virus
virus vaccines
vaccines
influenza
virus
Prior art date
Application number
IL249705A
Other languages
English (en)
Other versions
IL249705B (he
Inventor
Radosevic Katarina
Impagliazzo Antonietta
Wilem Meijberg Jan
Wagner Michelle
Ding Zhaoqing
Original Assignee
Radosevic Katarina
Janssen Vaccines And Prevention B V
Impagliazzo Antonietta
Wilem Meijberg Jan
Wagner Michelle
Ding Zhaoqing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2015/065663 external-priority patent/WO2016005482A1/en
Application filed by Radosevic Katarina, Janssen Vaccines And Prevention B V, Impagliazzo Antonietta, Wilem Meijberg Jan, Wagner Michelle, Ding Zhaoqing filed Critical Radosevic Katarina
Publication of IL249705A0 publication Critical patent/IL249705A0/he
Publication of IL249705B publication Critical patent/IL249705B/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
IL249705A 2014-07-10 2016-12-21 חיסונים נגד נגיף השפעת ושימושים בהם IL249705B (he)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP14176459 2014-07-10
US201462062754P 2014-10-10 2014-10-10
EP14195143 2014-11-27
EP15155761 2015-02-19
PCT/EP2015/065663 WO2016005482A1 (en) 2014-07-10 2015-07-09 Influenza virus vaccines and uses thereof

Publications (2)

Publication Number Publication Date
IL249705A0 true IL249705A0 (he) 2017-02-28
IL249705B IL249705B (he) 2021-03-25

Family

ID=72801266

Family Applications (1)

Application Number Title Priority Date Filing Date
IL249705A IL249705B (he) 2014-07-10 2016-12-21 חיסונים נגד נגיף השפעת ושימושים בהם

Country Status (1)

Country Link
IL (1) IL249705B (he)

Also Published As

Publication number Publication date
IL249705B (he) 2021-03-25

Similar Documents

Publication Publication Date Title
ZA201700165B (en) Influenza virus vaccines and uses thereof
SG11201610443WA (en) Influenza virus vaccines and uses thereof
SG10201913630YA (en) Zika virus vaccine
SMT202200361T1 (it) Vaccini contro virus respiratori
IL286265A (he) נגיף אמנון חדש ושימושיו
PL3393510T3 (pl) Szczepionka przeciwko wirusowi zika
SG11201803474UA (en) Vaccines against hepatitis b virus
ZA201700952B (en) Indoles for use in influenza virus infection
EP3119883A4 (en) Influenza virus vectors and uses therefor
ZA201509229B (en) Influenza virus vaccines and uses thereof
AP2017009834A0 (en) Fmdv recombinant vaccines and uses thereof
IL251895B (he) חיסוני 16hpv טיפוליים
GB201406608D0 (en) Virus
GB201613191D0 (en) Zika virus vaccine
SG11201702116VA (en) Viral rna segments as immunomodulatory agents and vaccine components
SG11201701279VA (en) Alkylated influenza vaccines
IL247185A0 (he) חיסונים לנגיף אמנון האגמים
GB201419572D0 (en) Virus
EP3240568A4 (en) Recombinant influenza virus vaccines for influenza and respiratory syncytial virus
EP3157950A4 (en) Influenza vaccines and methods of use thereof
IL249705B (he) חיסונים נגד נגיף השפעת ושימושים בהם
IL249704A0 (he) חיסונים נגד נגיף השפעת ושימושים בהם
HK1236965A1 (en) Influenza virus vaccines and uses thereof
PT3393510T (pt) Vacina contra o vírus zika
HK1259941A1 (en) Respiratory virus vaccines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed